Calidi Biotherapeutics Reports Third Quarter 2023 Operating and Financial Results
Go back to Calidi Biotherapeutics Reports Third Quarter 2023 Operating and Financial Results| (NYSE: CLDI) | Delayed: 1.36 -0.23 (14.47%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.59 | 52 Week High | $ | |||
| Open | $1.58 | 52 Week Low | $ | |||
| Day High | $1.58 | P/E | N/A | |||
| Day Low | $1.33 | EPS | $ | |||
| Volume | 295,380 | |||||

